Investment
Features
FeesSafety
Academy
More
Pluang+

Cboe seeks SEC approval for first U.S. 3x leveraged Bitcoin and Ether ETFs, targeting short-term traders.

Market News
14 Aug 2026
Coincu
View Source
Bullish
Cboe seeks SEC approval for first U.S. 3x leveraged Bitcoin and Ether ETFs, targeting short-term traders.

Cboe has filed for SEC approval to launch the first U.S.-listed ETFs offering triple-leveraged exposure to Bitcoin and Ether. These 3x leveraged ETFs aim to deliver three times the daily price movement of the underlying cryptocurrencies, making them higher-risk products designed for short-term trading rather than long-term holding. The SEC's decision will be crucial in determining whether these new leveraged crypto ETFs can enter the market, potentially expanding options for investors seeking amplified crypto exposure. This move follows other recent crypto ETF filings, highlighting ongoing innovation and regulatory scrutiny in the crypto fund space.

More News

First patient treated in clinical trial of IBA's innovative ConformalFLASH® proton therapy for head and neck cancer.

First patient treated in clinical trial of IBA's innovative ConformalFLASH® proton therapy for head and neck cancer.

IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...

Market News
Bullish
57 minutes ago
WISeQey lists on Nasdaq, aims to build secure AI and satellite platform for the Intelligence Age

WISeQey lists on Nasdaq, aims to build secure AI and satellite platform for the Intelligence Age

WISeQey Corp. completed its redomiciliation and began trading on Nasdaq and the SIX Swiss Exchange, marking a new phase focused on integrating its quantum cybersecurity, digital identity, and space IoT technologies. Its subsidiary WISeSat.Space also ...

Market News
Bullish
57 minutes ago
IBA treats first patient in clinical trial for innovative ConformalFLASH® proton therapy

IBA treats first patient in clinical trial for innovative ConformalFLASH® proton therapy

IBA has treated the first patient in the C-FLASH-01 clinical trial, testing its ConformalFLASH® proton therapy for head and neck cancer re-irradiation. This trial, led by Penn Medicine and approved by the FDA, explores ultra-high dose rate proton the...

Market News
Bullish
57 minutes ago
Sika to acquire Resonac's adhesives business, boosting growth in Asian automotive markets.

Sika to acquire Resonac's adhesives business, boosting growth in Asian automotive markets.

Sika AG has agreed to acquire the adhesives business of Japan's Resonac Corporation, which serves automotive customers across Asia. This acquisition will expand Sika's access to key Japanese automotive OEM suppliers and broaden its product offerings,...

Company Fundamentals
Bullish
57 minutes ago
Hudbay and Mitsubishi approve Copper World project, aiming for U.S. copper mine production by 2029

Hudbay and Mitsubishi approve Copper World project, aiming for U.S. copper mine production by 2029

Hudbay and Mitsubishi have approved the construction of the Copper World project, a major new copper mine in the U.S. This project is significant as it advances the development of a key resource mine, with production expected to begin in 2029. The ap...

Market News
Bullish
57 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App